biOasis Technologies Ord Shs V.BTI.H

Chrispi’s response

[ronrydell]

I should have included PEG's.....agreed that that strategics will buy but most announcements that I have seen have had completed trials...I, II, and III. ALTHOUGH if we get the long waited NR's that are great a pre trials deal could be done at a very low price. Hopefully that might happen...I'll look forward to discussing this with the investment bank that Deborah signed up with yesterday

[chrispi]

  https://www.evaluate.com/vantage/articles/data-insights/ma/following-ma-money-phase-and-therapy-area a bit dated as it’s from 2019: To help find these sweet spots Vantage has dug into biopharma’s M&A activity over the past five years, and found some clear trends.  For example, the majority of deals were struck over companies with preclinical or mid-stage assets, a